Year: 2024
Type: editorial
Abstract: Closing the addiction treatment gap and discovering new, more effective addiction medications are urgent priorities. In this regard, investigating the potential of glucagon-like peptide 1 analogue medications to treat substance use disorder deserves fast and rigorous testing.
Source: Addiction
DOI: 10.1111/add.16626
Authors: Nora D. Volkow, Rong Xu
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Rapid reverse translational drug repositioning, Collision of Alzheimers disease and COVID-19 pandemic in the United States: risks, outcomes, disparities and treatments, Characterize multifaceted interactions between COVID-19 and alcohol use disorder based on real-time analysis of electronic health records of 62 million adult patients, An Integrated Reverse Engineering Approach Toward Rapid drug Re positioning for Alzheimer's Disease, Collision of Alzheimers disease and COVID-19 pandemic in the United States: risks, outcomes, disparities and treatments
OpenAlex ID: W4401000963